OP-655 CCK2-receptor targeted PET/CT in patients with medullary thyroid cancer using [68Ga]Ga-DOTA-CCK-66 - first clinical experience [Abstract]
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: European Journal of Nuclear Medicine and Molecular Imaging, 50, Supplement 1, S. S297-
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2023
- Event
-
Veröffentlichung
- (who)
-
Springer
- (when)
-
2023
- Creator
-
Viering, Oliver
Guenther, T.
Holzleitner, N.
Wester, H.
Dierks, A.
Kircher, M.
Wienand, G.
Pfob, Christian H.
Bundschuh, Ralph A.
Lapa, Constantin Frederik Victor
- DOI
-
10.1007/s00259-023-06333-x
- URN
-
urn:nbn:de:bvb:384-opus4-1100430
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Viering, Oliver
- Guenther, T.
- Holzleitner, N.
- Wester, H.
- Dierks, A.
- Kircher, M.
- Wienand, G.
- Pfob, Christian H.
- Bundschuh, Ralph A.
- Lapa, Constantin Frederik Victor
- Universität Augsburg
- Springer
Time of origin
- 2023
Other Objects (12)
![CCK2 receptor–targeted PET/CT in medullary thyroid cancer using [68Ga]Ga-DOTA-CCK-66](/assets/placeholder/searchResultMediaUnknown.png)
CCK2 receptor–targeted PET/CT in medullary thyroid cancer using [68Ga]Ga-DOTA-CCK-66
Preclinical evaluation of minigastrin analogs and proof-of-concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 patients with medullary thyroid cancer
Standardized image quality for 68Ga-DOTA-TATE PET/CT
PET-CT imaging of pulmonary inflammation using [68Ga]Ga-DOTA-TATE
Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
Klinische Wertigkeit der PET/CT mit 68Ga-DOTA-TOC bei Thymom und Thymuskarzinom
18F-FDG PETCT and 68Ga-DOTA PETCT mismatch with in vivo histopathological characterization of low-grade neuroendocrine pancreatic tumor
68Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections
Initial clinical experience with 68Ga-DOTA-NOC prepared using 68Ga from nanoceria-polyacrylonitrile composite sorbent-based 68Ge/68Ga generator and freeze-dried DOTA-NOC kits
The value of [68Ga]Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors
Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report
Reduction of [68Ga]Ga-DOTA-TATE injected activity for digital PET/MR in comparison with analogue PET/CT
CCK2 receptor–targeted PET/CT in medullary thyroid cancer using [68Ga]Ga-DOTA-CCK-66
Preclinical evaluation of minigastrin analogs and proof-of-concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 patients with medullary thyroid cancer
Standardized image quality for 68Ga-DOTA-TATE PET/CT
PET-CT imaging of pulmonary inflammation using [68Ga]Ga-DOTA-TATE
Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
Klinische Wertigkeit der PET/CT mit 68Ga-DOTA-TOC bei Thymom und Thymuskarzinom
18F-FDG PETCT and 68Ga-DOTA PETCT mismatch with in vivo histopathological characterization of low-grade neuroendocrine pancreatic tumor
68Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections
Initial clinical experience with 68Ga-DOTA-NOC prepared using 68Ga from nanoceria-polyacrylonitrile composite sorbent-based 68Ge/68Ga generator and freeze-dried DOTA-NOC kits
The value of [68Ga]Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors
Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report
Reduction of [68Ga]Ga-DOTA-TATE injected activity for digital PET/MR in comparison with analogue PET/CT
CCK2 receptor–targeted PET/CT in medullary thyroid cancer using [68Ga]Ga-DOTA-CCK-66
Preclinical evaluation of minigastrin analogs and proof-of-concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 patients with medullary thyroid cancer
Standardized image quality for 68Ga-DOTA-TATE PET/CT
PET-CT imaging of pulmonary inflammation using [68Ga]Ga-DOTA-TATE
Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
Klinische Wertigkeit der PET/CT mit 68Ga-DOTA-TOC bei Thymom und Thymuskarzinom
18F-FDG PETCT and 68Ga-DOTA PETCT mismatch with in vivo histopathological characterization of low-grade neuroendocrine pancreatic tumor
68Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections
Initial clinical experience with 68Ga-DOTA-NOC prepared using 68Ga from nanoceria-polyacrylonitrile composite sorbent-based 68Ge/68Ga generator and freeze-dried DOTA-NOC kits
The value of [68Ga]Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors
Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report